Axe Compute

Axe Compute Earnings Yield

The Earnings Yield of Axe Compute (AGPU) as of Nov 2, 2026 is -2,815.10 %. In the previous year, Earnings Yield was -147.36 % — a change of 1,810.42% (lower).

Earnings Yield

-2,815.10 %

YoY

1,810.42%

Last updated:

Earnings Yield of Axe Compute is 2025 -2,815.10 % . Earnings Yield of Axe Compute was 2024 -147.36 % . It decreases by 1,810.42% lower compared to the previous year.

The Axe Compute Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2018
-121.81 USD
Jan 1, 2019
-234.18 USD
Jan 1, 2020
-312.61 USD
Jan 1, 2021
-237.40 USD
Jan 1, 2022
-310.83 USD
Jan 1, 2023
-168.88 USD
Jan 1, 2024
-147.36 USD
Jan 1, 2025
-2,815.10 USD
The Axe Compute Earnings Yield history
YEAREarnings YieldYoY
-2,815.10 %+1,810.42%
-147.36 %-12.75%
-168.88 %-45.67%
-310.83 %+30.93%
-237.40 %-24.06%
-312.61 %+33.49%
-234.18 %+92.25%
-121.81 %+68.02%
-72.50 %-8.01%
-78.81 %+36.23%
-57.86 %-29.90%
-82.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axe Compute Stock analysis

What does Axe Compute do? Predictive Oncology, Inc. generates revenue through its subsidiaries Helomics Holding Corporation and Skyline Medical Inc. Helomics applies artificial intelligence to patient tumor data to personalize cancer therapies and develop new-targeted therapies, offering CLIA-certified clinical testing for oncologists. Skyline Medical Inc. markets the STREAMWAY System, which automates medical fluid disposal, targeting hospitals and clinics globally. The company's products serve healthcare providers seeking advanced diagnostic and waste management solutions. Helomics focuses on personalized cancer treatment decisions using AI-driven analysis, while Skyline Medical Inc. provides automated fluid disposal systems. The STREAMWAY System is sold through domestic and international divisions to medical facilities requiring efficient waste handling. TumorGenesis Inc. supports laboratory-based tumor research, complementing Helomics' clinical offerings. The company's revenue streams include AI-based therapy personalization services and the STREAMWAY System sales. Healthcare providers, including oncologists and medical facilities, purchase these products to enhance treatment precision and operational efficiency. Subsidiaries operate under the parent company's structure, with Helomics handling AI applications and Skyline Medical managing medical device distribution. Axe Compute is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axe Compute stock

Earnings Yield of Axe Compute is -2,815.10 % in 2025.

Earnings Yield of Axe Compute changed from -147.36 % to -2,815.10 %, representing a 1,810.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Axe Compute since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Axe Compute with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Axe Compute

All Key Metrics — Axe Compute